RiteshRathoreMD

Oncology • Providence, RI

Gastrointestinal Cancer, Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Associate Professor, Medicine, Boston University School of Medicine

Join to view full profile

Dr. Rathore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rathore's full profile

Already have an account?

Office
825 Chalkstone Ave
Providence, RI 02908
Phone+1 401-456-2077

Fax+1 401-456-5765
Is this information wrong?

Education & Training

Brown UniversityFellowship, Hematology and Medical Oncology, 1997 - 2000
Maimonides Medical CenterResidency, Internal Medicine, 1994 - 1997
Delhi University- University College of Medical SciencesClass of 1991, MBBS

Certifications & Licensure

RI State Medical License 2000 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer Start of enrollment: 2012 May 01
Completed
Phase 1, Phase 2
BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial Start of enrollment: 2014 Aug 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

5 citations
Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base.
Shiva Kumar Reddy Mukkamalla, Donny V. Huynh, Ponnandai Somasundar, Ritesh Rathore> ;Frontiers in Oncology. 2020 Sep 15
4 citations
Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer:
Matthew J Keating, Lisa Giscombe, Toufic Tannous, Nishitha Reddy, Shiva Kumar Reddy Mukkamalla, Andre DeSouza, Ritesh Rathore> ;Journal of Oncology Pharmacy Practice. 2019 Mar 16
17 citations
Immune T cells can transfer and boost anti-breast cancer immunity
Archana Thakur, Ritesh Rathore, Sri Vidya Kondadasula, Joseph P. Uberti, Voravit Ratanatharathorn, Lawrence G. Lum> ;Oncoimmunology. 2018 Aug 27
8 citations
Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Can...
Jeffrey Reha, Shiva Kumar Reddy Mukkamalla, Ritesh Rathore, Ponnandai Somasundar> ;European Journal of Surgical Oncology. 2018 Jan 1
Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Re...
Ritesh Rathore, Mehrdad Abedi> ;The Prostate.
48 citations
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients.
Ulka N. Vaishampayan, Archana Thakur, Ritesh Rathore, Nicola Kouttab, Lawrence G. Lum> ;Prostate Cancer. 2015 Feb 23
75 citations
Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial
Lawrence G. Lum, Archana Thakur, Zaid Al-Kadhimi, Gerald A. Colvin, Francis J. Cummings, Robert D. Legare, Don S. Dizon, Nicola Kouttab, Abby Maizel, William Colaiace,...> ;Clinical Cancer Research. 2015 Feb 16
4 citations
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a survival analysis of a Brown University Oncology Group phase II study
Ariel E. Birnbaum, Thomas A. DiPetrillo, Ritesh Rathore, Priscilla Merriam, Harry Wanebo, Anthony George Thomas, Yacoub Puthawala, Donald Joyce, Denise Luppe, Humera K...> ;American Journal of Clinical Oncology. 2014 Apr 1
21 citations
Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: A pilot study
Lawrence G. Lum, Archana Thakur, Cassara Pray, Nicola Kouttab, Mehrdad Abedi, Abhinav Deol, William Colaiace, Ritesh Rathore> ;Bone Marrow Transplantation. 2014 Jan 1
16 citations
Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck.
Neal Ready, Ritesh Rathore, Tirrell T. Johnson, A. Nadeem, Prakash Chougule, Charles Ruhl, K. Radie-Keane, Kathy Puyana Theall, Harold J. Wanebo, Jennifer Marcello, Te...> ;American Journal of Clinical Oncology. 2012 Feb 1
T-cells targeted with anti-CD3 x anti-HER2 bispecific antibody for treatment of women with stage IV breast cancer (phase I): Clinical and immune function results.
Lum LG, Rathore R, Al-Kadhimi Z, Davol P, Thakur A, Pray C, Liu Q, Tomaszewski E, Cummings F, Steele P, Wedge J, Kouttab N, Maizel A, Colaiace W, Joyrich R, Ratanathar...> ;J. Clin. Oncol.. 2011-05-20
4 citations
Selective Organ Preservation in Operable Locally Advanced Head and Neck Squamous Cell Carcinomas Guided by Primary Site Restaging Biopsy: Long-Term Results of Two Sequ...
Harold J. Wanebo, Ritesh Rathore, Prakash Chougule, Michael R. DiSiena, R. James Koness, Robert G. McRae, P. Nigri, K. Radie-Keane, Neal Ready> ;Annals of Surgical Oncology. 2011 May 7
Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).
Ritesh Rathore, Ariel E. Birnbaum, Bharti Rathore, Thomas A. DiPetrillo, Teresa Kennedy, Neal Ready> ;Cancer Chemotherapy and Pharmacology. 2010 Feb 4
17 citations
Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a brown university oncology group study.
Ritesh Rathore, Howard Safran, Greg Soares, Greg Dubel, Brendan McNulty, Sun Ahn, David A. Iannitti, Teresa Kennedy> ;American Journal of Clinical Oncology. 2010 Feb 1
1 citations
Triple MEL100 Therapy in Multiple Myeloma
David Berz, Gerald A. Colvin, Elise M. McCormack, Eric S. Winer, Patricia Karwan, L. Colvin, Ritesh Rathore, Lawrence G. Lum, Gerald J. Elfenbein, Peter J. Quesenberry> ;Transplantation Proceedings. 2009 Nov 1
13 citations
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis.
Ariel E. Birnbaum, Thomas A. DiPetrillo, Ritesh Rathore, Elliott Anderson, Harry Wanebo, Yacoub Puthwala, Donald Joyce, Howard Safran, Denise Henderson, Theresa Kenned...> ;American Journal of Clinical Oncology. 2009 Sep 1
Phase I immunotherapy in women with metastatic breast cancer with activated T cells targeted with anti-CD3 x anti-Her2/neu bispecific antibody.
Lum LG, Al-Kadhimi Z, Skuba C, Sandborg R, Rathore R, Liu Q, Uberti JP, Ratanatharathorn V> ;J. Clin. Oncol.. 2008-05-20
19 citations
Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group...
Prakash Chougule, Muhammad S. Akhtar, Ritesh Rathore, James Koness, Robert G. McRae, P. Nigri, Kathie Radie-Keane, Teresa Kennedy, Harold J. Wanebo, Neal Ready> ;Head & Neck. 2008 Mar 1
Hepatic arterial infusion (HAI) of oxaliplatin in advanced hepatocellular cancer (HCC): A phase I study.
Rathore R, Iannitti D, Soares G, Wanebo H, Maia-Aucna C, Safran H> ;J. Clin. Oncol.. 2006-06-20
69 citations
Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.
Ursula Reusch, Magesh Sundaram, Pamela A. Davol, Sarah D. Olson, James B. Davis, Kurt Demel, Julie Nissim, Ritesh Rathore, Paul Y. Liu, Lawrence G. Lum> ;Clinical Cancer Research. 2006 Jan 1
9 citations
Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.
James Y Tsai, David A. Iannitti, Anna Berkenblit, Paul A. Akerman, A. Nadeem, Ritesh Rathore, David P. Harrington, Dean Roye, Thomas J. Miner, John Mark Barnett, Chris...> ;American Journal of Clinical Oncology. 2005 Aug 1
142 citations
Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/neu
Howard Safran, David A. Iannitti, Ramesh K. Ramanathan, Jonathan D. Schwartz, Margaret M. Steinhoff, Chris Nauman, Paul J. Hesketh, Ritesh Rathore, Robert A. Wolff, Um...> ;Cancer Investigation. 2004 Nov 10
Phase I/II study of docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer.
Tsai JY, Berkenblit A, Akerman P, Nadeem A, Rathore R, Harrington D, Roye D, Stuart K, Kennedy TA, Safran H> ;J. Clin. Oncol.. 2004-07-15
44 citations
Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study.
Howard Safran, Thomas A. DiPetrillo, A. Nadeem, Margaret M. Steinhoff, Umadevi Tantravahi, Ritesh Rathore, Harold J. Wanebo, Marilyn Hughes, Chris Maia, James Y Tsai, ...> ;Cancer Investigation. 2004 Jan 1
1 citations
The chronic leukemias: current and novel therapeutic approaches.
Ritesh Rathore, Gerald J. Elfenbein> ;Medicine and Health, Rhode Island. 2003 Aug 1
Join now to see all

Press Mentions

TriSalus Life Sciences : And Roger Williams Medical Center Announce Initiation of Phase 1 Clinical Trial for a Novel Delivery Technology That Can Enhance Drug Delivery into Pancreatic TumorsFebruary 12th, 2020

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Roger Williams Medical CenterProvidence, Rhode Island